Obstructive sleep apnea, hypertension, and wakefulness-promoting agents.
Section of Clinical Pharmacology and Hypertension, Division of Nephrology, Box 980160, MCV Station, Virginia Commonwealth University, Richmond, VA 23298-0160, USA.
Dan
D
Carl
Domenic A
DA
Sica
D001559:Benzhydryl Compounds / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use*; D002940:Circadian Rhythm / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000209:etiology* / Q000503:physiopathology; D000077408:Modafinil; D009765:Obesity / Q000150:complications; D020181:Sleep Apnea, Obstructive / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D014851:Wakefulness / Q000187:drug effects*
D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D000077408:Modafinil